Search results
FDA grants priority review for Neurocrine’s crinecerfont NDAs
Pharmaceutical Technology· 3 days agoApproval of crinecerfont would also allow Neurocrine to utilise its rare paediatric disease...
Strategies to address the viral vector manufacturing shortage
Pharmaceutical Technology· 4 days agoWith the exciting promise of addressing previously unmet medical needs, the rapidly growing field of...
FDA approves Shorla Oncology’s TEPYLUTE for cancer treatment
Pharmaceutical Technology· 4 days agoThe FDA has accepted SH-201 for NDA review in April 2024, with an approval decision anticipated by...
A growing scourge of rare genetic diseases and why it matters for India
Financial Express· 4 days agoA peep into the human genomic makeup is no more the preserve of the well-heeled. Today, thanks to...
Modernizing cell culture processes for the next wave of genomic medicine
Pharmaceutical Technology· 4 days agoWith genomic medicine gaining clinical momentum, developers are looking for more robust ways to...